Coronary Stenosis Clinical Trials
2 recruiting trials for Coronary Stenosis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Coronary Stenosis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of British Columbia (1), Seung-Jung Park (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Percutaneous Coronary Intervention (PCI) (procedure, 1 trial).
Track Coronary Stenosis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS...
Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty...
Asan Medical Center Myocardial Infarction Registry
This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Coronary Stenosis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Coronary Stenosis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Coronary Stenosis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.